From The Team

This item is over 2 years old; some content may no longer be current

This page provides the specific methodology used for each data story featured in EPiC Antibiotics.

This item is over 2 years old; some content may no longer be current

Our August newsletter is all about asthma, coinciding with the Asthma + Respiratory Foundation (ARFNZ) Breathe Better September campaign. We highlight the new EPiC Asthma dashboard, our asthma resource hub, bulletin #17, and asthma courses available through ARFNZ and Asthma NZ.  

Read the newsletter here.

This item is over 2 years old; some content may no longer be current

This page provides the specific methodology used for each data story featured in EPiC Asthma.

This item is over 2 years old; some content may no longer be current

Our August newsletter features new asthma content, including an article on the changes to recommended asthma management and a free webinar. You'll also find links to the EPiC data club, an EPiC Cilazapril update, and the latest bulletin. 

Read the newsletter here.

This item is over 2 years old; some content may no longer be current

A consultant general practitioner from Botany Junction Medical is the winner of a $2000 travel voucher after logging into the new He Ako Hiringa EPiC dashboard. Click here to read more. 

Contributor
He Ako Hiringa
This item is over 2 years old; some content may no longer be current

Our July newsletter is EPiC! Explore our new EPiC user guide, apply for an EPiC practice account, and register for the EPiC data club. We also feature our Accuretic article and bulletin #15. 

Read the newsletter here.

 

This item is over 2 years old; some content may no longer be current

Our June newsletter features the new EPiC CVD dashboard, a Q&A list about the adalimumab funding changes, a bulletin on health managers and equity, and our new Focus magazine. 

Read the newsletter here.

This item is over 2 years old; some content may no longer be current

This page provides the specific methodology used for each data story featured in EPiC CVD.

This item is over 2 years old; some content may no longer be current

Our May newsletter features a summary comparison of molnupiravir with nirmatrelvir/ritonavir (Paxlovid), a bulletin on Paxlovid, our CVD workbook, and a short animated video highlighting patients' thoughts on changing from Humira to Amgevita.

Read the newsletter here.

This item is over 2 years old; some content may no longer be current

This FAQ list answers common questions about EPiC.